2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with Hepatitis C, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benzon, B; Ključević, N; Ključević, Ž; Sutlović, D; Veršić Bratinčević, M | 1 |
1 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Hepatitis C, Chronic
Article | Year |
---|---|
Liver damage indices as a tool for modifying methadone maintenance treatment: a cross-sectional study.
Topics: Adult; Analgesics, Opioid; Aspartate Aminotransferases; Cross-Sectional Studies; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Platelet Count; Pyrrolidines | 2018 |